Lipoprotein (a): a risk factor for peripheral vascular disease

Area of Science:

• Cardiovascular Medicine
• Clinical Chemistry
• Epidemiology

Background:

• Lipoprotein (a) [Lp(a)] is a known predictor of coronary and cerebrovascular disease complications.
• Peripheral vascular disease (PVD) is a significant health concern with multiple associated risk factors.
• Understanding novel risk factors for PVD is crucial for effective prevention and management.

Purpose of the Study:

• To compare plasma Lp(a) levels in white male patients with and without PVD.
• To determine if Lp(a) is an independent risk factor for PVD.
• To assess the role of Lp(a) in relation to established risk factors like smoking, diabetes, and coronary artery disease.

Main Methods:

• A comparative study involving 100 white male patients, with 50 diagnosed with PVD and 50 without.
• Plasma Lp(a) levels were measured and compared between the two groups.
• Statistical analyses, including stepwise regression, were used to evaluate Lp(a) as an independent predictor of PVD, controlling for smoking, diabetes mellitus (DM), and coronary artery disease (CAD).

Main Results:

• Patients with PVD exhibited significantly higher plasma Lp(a) levels compared to those without PVD (29.8 vs. 20.0 mg/dl, p=0.04).
• While PVD patients had higher rates of smoking, DM, and CAD, Lp(a) remained a significant predictor.
• Interestingly, patients with DM had lower Lp(a) levels than those without DM (p=0.04).

Conclusions:

• Elevated Lp(a) levels are significantly correlated with the incidence of PVD in white males.
• Lp(a) serves as an independent risk factor for PVD, distinct from smoking, diabetes, and coronary artery disease.
• Further research into Lp(a) as a therapeutic target for PVD may be warranted.